or Try an Advanced Search...

    Technical Analysis for HLS - HLS Therapeutics Inc

    Grade Last Price % Change Price Change
    F 4.140 4.28% 0.170
    HLS closed up 4.28 percent on Thursday, May 16, 2024, on 17 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical HLS trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Pocket Pivot Bullish Swing Setup 4.28%
    Narrow Range Bar Range Contraction 4.28%
    Lower Bollinger Band Walk Weakness 4.28%
    Wide Bands Range Expansion 4.28%
    Up 3 Days in a Row Strength 4.28%
    Gapped Down Weakness 4.28%
    Older End-of-Day Signals for HLS ...

       Recent Intraday Alerts

    Alert Time
    Up 1 ATR about 19 hours ago
    Up 3% about 19 hours ago
    Up 2% about 19 hours ago
    Up 1% about 19 hours ago
    Rose Above Previous Day's High about 20 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    HLS Chart by TradingView
    Basic chart:

    Profile

    HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Life Sciences Pharmaceutical Products Schizophrenia

    Is HLS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.12
    52 Week Low 3.34
    Average Volume 11,409
    200-Day Moving Average 4.536
    50-Day Moving Average 4.376
    20-Day Moving Average 4.540
    10-Day Moving Average 4.311
    Average True Range 0.168
    RSI (14) 40.12
    ADX 28.04
    +DI 30.269
    -DI 46.558
    Chandelier Exit (Long, 3 ATRs) 4.926
    Chandelier Exit (Short, 3 ATRs) 4.274
    Upper Bollinger Bands 5.254
    Lower Bollinger Band 3.826
    Percent B (%b) 0.22
    BandWidth 31.445
    MACD Line -0.127
    MACD Signal Line -0.028
    MACD Histogram -0.0992
    Fundamentals Value
    Market Cap 131.74 Million
    Num Shares 31.8 Million
    EPS -0.90
    Price-to-Earnings (P/E) Ratio -4.61
    Price-to-Sales 8.55
    Price-to-Book 2.89
    Dividend 0.16
    Dividend Yield 3.86%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.350
    Resistance 3 (R3) 4.327 4.233 4.315
    Resistance 2 (R2) 4.233 4.180 4.245 4.303
    Resistance 1 (R1) 4.187 4.147 4.210 4.210 4.292
    Pivot Point 4.093 4.093 4.105 4.105 4.093
    Support 1 (S1) 4.047 4.040 4.070 4.070 3.988
    Support 2 (S2) 3.953 4.007 3.965 3.977
    Support 3 (S3) 3.907 3.953 3.965
    Support 4 (S4) 3.930